Navigation Links
Eurofins MWG Operon, Inc. Names James Corne as Director of Marketing
Date:8/1/2013

Huntsville, AL (PRWEB) August 01, 2013

James Corne has joined Eurofins MWG Operon, Inc. as their new Director of Marketing. Corne envisions a unique brand experience for Eurofins customers, which will include improved convenience, quality, and service. Previously, Corne served as the Marketing Director for several organizations, including the Virginia’s Local Energy Alliance Program and in Pennsylvania at Penn State University’s Sustainability Office. Corne was also a Global Systems Developer at PepsiCo International and consulted with Verizon on a large-scale marketing and sustainability initiative.

“Eurofins MWG Operon intentionally recruited someone outside the genomics industry to gain an outsider’s unique and valuable perspective,” stated Martin Kunz, CEO. “James’ marketing expertise, specifically brand management and marketing strategy, will now focus on our commitment to continually increase client satisfaction.”

“It is an honor to join this cutting edge, quality-obsessed company,” stated Corne. “I hope that the marketing team will not only advance Eurofins MWG Operon in terms of brand awareness and overall efficiency, but also further support the research of our customers. These esteemed scientists, companies, and academic researchers will change the world, and everyone at our company carries a sincere passion to serve their needs.”

About Eurofins MWG Operon

Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in the United States, Europe, and Asia, is an international provider of DNA sequencing services, DNA synthesis products, and bioinformatics services for academic and industrial research. The company’s strengths are its strong customer orientation, fast service, and high quality. For additional information, please visit our website at: operon.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10984191.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
2. SimpleSeq Webless by Eurofins MWG Operon for Order-Free DNA Sequencing
3. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
4. Eurofins MWG Operon’s Express Oligos Provide Faster Than Ever Service
5. Raleigh Chamber Names Bob Riedford to Board of Advisors
6. RRD International Names J. Scott Tarrant President
7. BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
8. Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer
9. ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development
10. Regenesis Biomedical Names Scott Brooks Chief Executive Officer
11. Tunnell Consulting Names John S. Ross as Principal, Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)... -- AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), a ... a majority-owned subsidiary of Intrexon Corporation (NYSE: ... of its common shares on the NASDAQ Stock Market ... "AquaBounty,s listing on NASDAQ represents an important milestone for ... U.S. markets as we advance plans for commercial production ...
(Date:1/19/2017)... Linda, Ca (PRWEB) , ... January 18, 2017 ... ... virtual events for tech innovators, engineers, and scientists from around the world, was ... American News. The awards program is based entirely on merit and decided upon ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... drug and device development, and Prism Clinical Research , a leader in ... Verified Clinical Trials (VCT) has been selected by both companies as ...
Breaking Biology Technology:
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)... 12, 2017 A new report by Allied Market Research, titled, ... biometric technology market is expected to generate revenue of $10.72 billion by 2022, with ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the ...
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., a ... scanning technology for automotive at CES® 2017. Delta ID ... ) to demonstrate the use of iris scanning as ... authenticate the driver in a car, and as a ... driving experience. Delta ID and Gentex will ...
Breaking Biology News(10 mins):